Home
Market Capitalization of Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd
NSE: SANDUPHARMA
Market Cap
Key Highlights
- The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 51.76 crore as of 21 Feb 25 .
- The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 53.58 as of 21 Feb 15:30 .
- The dividend payouts of Sandu Pharmaceuticals Ltd changed from ₹ 0.5 to ₹ 0.8 over 4 quarters. This represents a CAGR of 60.00% .

Sandu Pharmaceuticals Ltd
NSE: SANDUPHARMA
Share Price
Market Price of Sandu Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 53.58 |
20 Feb 2025 | 53.12 |
19 Feb 2025 | 53 |
18 Feb 2025 | 53.43 |
17 Feb 2025 | 52.13 |
14 Feb 2025 | 53.33 |
13 Feb 2025 | 50.58 |
12 Feb 2025 | 51.75 |
11 Feb 2025 | 51.1 |
10 Feb 2025 | 51.52 |
BlinkX Score for Sandu Pharmaceuticals Ltd
Asset Value vs Market Value of Sandu Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Sandu Pharmaceuticals Ltd
Historical P/E Ratio of Sandu Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sandu Pharmaceuticals Ltd
Historical Revenue of Sandu Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Sandu Pharmaceuticals Ltd
Historical EBITDA of Sandu Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sandu Pharmaceuticals Ltd
Historical Net Profit of Sandu Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sandu Pharmaceuticals Ltd
Historical Dividend Payouts of Sandu Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Sandu Pharmaceuticals Ltd
About Sandu Pharmaceuticals Ltd
- Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
- The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
- This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
- Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
- Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
Sandu Pharmaceuticals Ltd News Hub
Sandu Pharmaceuticals AGM scheduled
Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he
Read more
13 Aug 24
Board of Sandu Pharmaceuticals recommends final dividend
Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12
Read more
13 Aug 24
Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter
Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a
Read more
13 Aug 24
Sandu Pharmaceuticals schedules board meeting
Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024
Read more
06 Aug 24